DARA is a specialty Pharmaceutical Company focused on the development and commercialization of oncology treatment and supportive care. DARA holds the exclusive U.S. marketing rights to Soltamox®, a novel oral liquid formulation of tamoxifen citrate, a product used widely in the treatment and prevention of breast cancer. Soltamox is the only FDA approved oral liquid version of tamoxifen citrate and fulfills a vital clinical need for patients who cannot tolerate existing tablet formulations of this drug. DARA has also obtained exclusive U.S. commercial rights for Bionect® (hyaluronic acid sodium salt, 0.2%) within the oncology and radiation oncology marketplace. Bionect is an FDA-cleared product indicated for the management of irritation of the skin.
View Top Employees from Dara BiosciencesWebsite | https://www.darabio.com |
Ticker | NASDAQ:DARA |
Employees | 8 (8 on RocketReach) |
Founded | 2002 |
Address | 8540 Colonnade Center Dr, Ste 101, Raleigh, North Carolina 27615, US |
Phone | (919) 872-5578 |
Fax | (919) 861-0239 |
Technologies | |
Industry | Pharmaceuticals, Drug Manufacturing & Research, Biotechnology, Specialty Pharmaceuticals, Science and Engineering, Oncology, Healthcare, Developer Platform, Oncology Supportive Care, Software, Pharmaceutical, Health Care |
Web Rank | 21 Million |
Keywords | Darbiosciences |
Competitors | Affectis Pharmaceuticals, Aptahem, BioLineRx, Merrion Pharmaceuticals Plc, Quince Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Dara Biosciences employee's phone or email?
Len Tenzer is the Vice President of Sales and Marketing of Dara Biosciences.
8 people are employed at Dara Biosciences.
Dara Biosciences is based in Raleigh, North Carolina.
The NAICS codes for Dara Biosciences are [32541, 32, 3254, 325].
The SIC codes for Dara Biosciences are [283, 28].